search
Back to results

Effectiveness of a Cardiac Rehabilitation Program in Patients With Heart Failure

Primary Purpose

Heart Failure

Status
Active
Phase
Not Applicable
Locations
Colombia
Study Type
Interventional
Intervention
Interdisciplinary educational program
Sponsored by
Grupo Rehabilitacion en Salud
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Heart Failure

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age over 18 years.
  • Spanish language.
  • Live in Medellin or near the city municipalities.
  • Available to attend the face-up meetings.
  • Accepts to participate in the study.
  • Have completed Phase II cardiac rehabilitation.
  • Have a confirmed diagnosis of heart failure with ejection fraction measured by echocardiography, scintigraphy or cardiac resonance. For cases with expulsion fraction> 40%, it is required to have high levels of natriuretic peptides.
  • New York Heart Association (NYHA) functional class II and III.

Exclusion Criteria:

  • Acute coronary syndrome not treated in the last month.
  • Severe symptomatic aortic stenosis.
  • Atrial fibrillation with uncontrolled ventricular response.
  • Symptomatic or hemodynamic compromise cardiac arrhythmias.
  • New York Heart Association (NYHA) functional class IV or that requires the use of parenteral medications such as diuretics or inotropics (in-hospital or outpatient).
  • Myocarditis or acute pericarditis.
  • Previous aortic dissection.
  • Poorly controlled systemic arterial hypertension.
  • Recent pulmonary thromboembolism.
  • Chronic obstructive pulmonary disease.
  • Restrictive lung disease.
  • Osteomuscular disease that limits physical activity.
  • Cognitive and / or behavioral disorders that prevent the understanding of instructions.
  • Difficulty in developing questionnaires in Spanish due to cultural differences.
  • Diabetes mellitus decompensated.
  • Be participating in another clinical trial.
  • Participants who previously did NOT complete the cardiac rehabilitation program.

Sites / Locations

  • Clinica de Las Américas

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Intervention

Control

Arm Description

Consists of 3 interdisciplinary educational sessions and Face-to-face with a fortnightly telephone follow-up and text messages. Each session will be directed by medical staff (cardiologist and / or physiatrist) and supported by other health professionals (physical therapist, occupational therapist, nutritionist and psychologist). The educational sessions, include the topics "knowledge of the disease", "recognition of alarm signs", "pharmacological treatment", "healthy lifestyle habits", "mental health" and "regular aerobic exercise"; The entire educational component will be based on the Colombian clinical practice guide for the prevention, diagnosis, treatment and rehabilitation of heart failure.

Once the patient ends phase II of the cardiac rehabilitation program, he/she will receive the usual care, which consists of a 5-minute educational intervention by a physiatrist at the end of the functional test, where recommendations are given on healthy lifestyle habits, adherence to pharmacological treatment and regular aerobic exercise. This educational intervention will be performed after each of the functional tests (at the end of phase II of the program and during the follow-up of patients at months 1, 3, 6 and 12 during Phase III of the program) performing 5 educational interventions in total .

Outcomes

Primary Outcome Measures

Adherence to the program in one year (Questionnaire)
The proportion of adherent patients will be estimated one year after the end of phase II of cardiac rehabilitation in each arm of the study and the relative risk will be calculated with their respective 95% confidence interval.

Secondary Outcome Measures

Adherence to the program at 1, 3 and 6 months (Questionnaire)
The proportion of adherent patients will be estimated in each of the periods followed (1, 3 and 6 months) after the end of phase II of cardiac rehabilitation in each arm of the study. The relative risk will be calculated with its respective 95% confidence interval for each of the periods.
Functional performance (Stress test with exercise)
Stress test
Minnesota Living with heart Failure Questionnaire and The Duke Activity Status Index (DASI)
Minnesota Living with heart Failure Questionnaire and The Duke Activity Status Index (DASI)
Return to phase II of rehabilitation
Return to phase II of rehabilitation
Hospitalizations
Hospitalizations due to cardiac disease
Death
Death of cardiac diseases or other causes

Full Information

First Posted
December 17, 2019
Last Updated
October 26, 2022
Sponsor
Grupo Rehabilitacion en Salud
Collaborators
Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS), Universidad de Antioquia, Clinica Las Americas
search

1. Study Identification

Unique Protocol Identification Number
NCT04245813
Brief Title
Effectiveness of a Cardiac Rehabilitation Program in Patients With Heart Failure
Official Title
Effectiveness of a Cardiac Rehabilitation Program in Patients With Heart Failure
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
December 23, 2019 (Actual)
Primary Completion Date
October 26, 2022 (Actual)
Study Completion Date
May 15, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Grupo Rehabilitacion en Salud
Collaborators
Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS), Universidad de Antioquia, Clinica Las Americas

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Heart failure is a devastating disease with great impact on the quality of life and survival of those who suffer from it. The disease has a high prevalence and its treatment represents high economic costs for health systems. In Colombia, cardiovascular diseases that are part of chronic noncommunicable diseases are the first cause of death. According to figures from the World Health Organization (WHO) in 2014, 28% of deaths in the country were due to cardiovascular diseases. Pharmacological treatment, patient education and regular physical activity are the cornerstones for the treatment of heart failure and therefore the international clinical practice guidelines as well as the guide of the Colombian Ministry of Health recommend the performance of supervised physical exercise for patients with the disease. Cardiac rehabilitation programs using regular and supervised aerobic exercise positively impact the lives of these patients by improving functional capacity, quality of life, psychological well-being and can have an effect on important outcomes. such as hospitalizations and mortality. The Health Rehabilitation Group has carried out several research projects on heart failure and other cardiovascular diseases, and in agreement with the Ministry of Health and Social Protection (COLCIENCIAS) developed the Clinical Practice Guide for the Prevention, Diagnosis, Treatment and Rehabilitation of Heart Failure in population over 18 years of age classification B, C and D. The group's research has demonstrated the efficacy and safety of cardiac rehabilitation to improve functional capacity, abdominal perimeter and systemic blood pressure figures in patients with cardiovascular diseases, improvement in the quality of life in patients with heart failure and the prevalence of musculoskeletal diseases has even been described in this group of patients. In one of the studies, an exercise program was compared with an educational program and it was concluded that the exercise was effective in improving the health-related quality of life of patients with heart failure. Despite the benefits demonstrated by the cardiac rehabilitation programs, the adherence to exercise of the patients is low, especially during phase III of the program in which patients exercise in an unsupervised manner with periodic care follow-up. In some studies they have carried out other types of follow-up such as telephone control, home visits and telemonitoring, but there are no studies that carry out a low-cost program, with telephone follow-up and distance education to improve adherence in the phase III of cardiac rehabilitation. The aim of this study is to determine the effect of an education, follow-up and stimulus program of adherence to the achievements of phase III of the Rehabilitation Program in patients with heart failure, on functional capacity, quality of life, the need to return to phase II of the program and rehospitalizations.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized controlled clinical trial
Masking
Care ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
144 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention
Arm Type
Experimental
Arm Description
Consists of 3 interdisciplinary educational sessions and Face-to-face with a fortnightly telephone follow-up and text messages. Each session will be directed by medical staff (cardiologist and / or physiatrist) and supported by other health professionals (physical therapist, occupational therapist, nutritionist and psychologist). The educational sessions, include the topics "knowledge of the disease", "recognition of alarm signs", "pharmacological treatment", "healthy lifestyle habits", "mental health" and "regular aerobic exercise"; The entire educational component will be based on the Colombian clinical practice guide for the prevention, diagnosis, treatment and rehabilitation of heart failure.
Arm Title
Control
Arm Type
No Intervention
Arm Description
Once the patient ends phase II of the cardiac rehabilitation program, he/she will receive the usual care, which consists of a 5-minute educational intervention by a physiatrist at the end of the functional test, where recommendations are given on healthy lifestyle habits, adherence to pharmacological treatment and regular aerobic exercise. This educational intervention will be performed after each of the functional tests (at the end of phase II of the program and during the follow-up of patients at months 1, 3, 6 and 12 during Phase III of the program) performing 5 educational interventions in total .
Intervention Type
Behavioral
Intervention Name(s)
Interdisciplinary educational program
Intervention Description
Interdisciplinary educational component based on the Clinical Practice Guide for Heart Failure
Primary Outcome Measure Information:
Title
Adherence to the program in one year (Questionnaire)
Description
The proportion of adherent patients will be estimated one year after the end of phase II of cardiac rehabilitation in each arm of the study and the relative risk will be calculated with their respective 95% confidence interval.
Time Frame
One year
Secondary Outcome Measure Information:
Title
Adherence to the program at 1, 3 and 6 months (Questionnaire)
Description
The proportion of adherent patients will be estimated in each of the periods followed (1, 3 and 6 months) after the end of phase II of cardiac rehabilitation in each arm of the study. The relative risk will be calculated with its respective 95% confidence interval for each of the periods.
Time Frame
Months 1, 3 and 6
Title
Functional performance (Stress test with exercise)
Description
Stress test
Time Frame
Months 1, 3, 6 and 12
Title
Minnesota Living with heart Failure Questionnaire and The Duke Activity Status Index (DASI)
Description
Minnesota Living with heart Failure Questionnaire and The Duke Activity Status Index (DASI)
Time Frame
Months 1, 3, 6 and 12
Title
Return to phase II of rehabilitation
Description
Return to phase II of rehabilitation
Time Frame
Months 1, 3, 6 and 12
Title
Hospitalizations
Description
Hospitalizations due to cardiac disease
Time Frame
Months 1, 3, 6 and 12
Title
Death
Description
Death of cardiac diseases or other causes
Time Frame
Months 1, 3, 6 and 12

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age over 18 years. Spanish language. Live in Medellin or near the city municipalities. Available to attend the face-up meetings. Accepts to participate in the study. Have completed Phase II cardiac rehabilitation. Have a confirmed diagnosis of heart failure with ejection fraction measured by echocardiography, scintigraphy or cardiac resonance. For cases with expulsion fraction> 40%, it is required to have high levels of natriuretic peptides. New York Heart Association (NYHA) functional class II and III. Exclusion Criteria: Acute coronary syndrome not treated in the last month. Severe symptomatic aortic stenosis. Atrial fibrillation with uncontrolled ventricular response. Symptomatic or hemodynamic compromise cardiac arrhythmias. New York Heart Association (NYHA) functional class IV or that requires the use of parenteral medications such as diuretics or inotropics (in-hospital or outpatient). Myocarditis or acute pericarditis. Previous aortic dissection. Poorly controlled systemic arterial hypertension. Recent pulmonary thromboembolism. Chronic obstructive pulmonary disease. Restrictive lung disease. Osteomuscular disease that limits physical activity. Cognitive and / or behavioral disorders that prevent the understanding of instructions. Difficulty in developing questionnaires in Spanish due to cultural differences. Diabetes mellitus decompensated. Be participating in another clinical trial. Participants who previously did NOT complete the cardiac rehabilitation program.
Facility Information:
Facility Name
Clinica de Las Américas
City
Medellin
State/Province
Antioquia
Country
Colombia

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effectiveness of a Cardiac Rehabilitation Program in Patients With Heart Failure

We'll reach out to this number within 24 hrs